Apotex Corp. 2025-10-08 Health serious FDA
Health · FDA · Recall #FDA-D-0676-2025
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10… Recall
Issued October 8, 2025 · Apotex Corp.
In October 2025, Apotex Corp. recalled the Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
What you should do
- 1 Stop using Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5%, a) 5 mL and b) 10… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Apotex Corp. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Apotex Corp.
- Category
- Health
- Recall date
- October 8, 2025
- Units affected
- Not reported
- Sold at
- Nationwide in the US
- Recall number
- FDA-D-0676-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- Apotex Corp. has 9 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.